Kronos Bio Files Q1 2025 10-Q
| Field | Detail |
|---|---|
| Company | Kronos Bio, Inc. |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
Kronos Bio's Q1 2025 10-Q is in: financials updated, check it out.
AI Summary
Kronos Bio, Inc. filed its quarterly report for the period ending March 31, 2025. The company reported its financial position and results of operations, including details on common stock, additional paid-in capital, and retained earnings for both the current quarter and the preceding fiscal year-end. The filing also includes information on the company's business address and phone number.
Why It Matters
This filing provides investors with an update on Kronos Bio's financial health and operational performance for the first quarter of 2025, crucial for assessing investment value.
Risk Assessment
Risk Level: medium — As a biotechnology company, Kronos Bio faces inherent risks related to drug development, regulatory approvals, and market competition, which are not fully detailed in this summary financial filing.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2024-12-31 — Previous Fiscal Year End Date (Provides a comparison point for financial performance.)
- 2024-01-01 to 2024-03-31 — Prior Year Q1 Period (Context for year-over-year financial comparison.)
Key Players & Entities
- Kronos Bio, Inc. (company) — Filer of the 10-Q report
- 2025-03-31 (date) — End of the reporting period
- 2025-01-01 (date) — Start of the reporting period
- 1300 S. EL CAMINO REAL SUITE 400 (address) — Company's business and mailing address
- SAN MATEO, CA 94402 (address) — Company's business and mailing city, state, and zip
FAQ
What is the primary purpose of this 10-Q filing?
This 10-Q filing provides Kronos Bio, Inc.'s unaudited financial statements and management's discussion and analysis for the quarterly period ended March 31, 2025.
What is Kronos Bio, Inc.'s business address?
Kronos Bio, Inc.'s business address is 1300 S. EL CAMINO REAL, SUITE 400, SAN MATEO, CA 94402.
What fiscal year end does Kronos Bio, Inc. observe?
Kronos Bio, Inc. observes a fiscal year end of December 31.
What are the key financial statement components mentioned for the reporting period?
The filing mentions components such as us-gaap:CommonStockMember, us-gaap:AdditionalPaidInCapitalMember, us-gaap:AccumulatedOtherComprehensiveIncomeMember, and us-gaap:RetainedEarningsMember for the period ending March 31, 2025.
When was this 10-Q filing submitted?
This 10-Q filing was submitted on May 8, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Kronos Bio, Inc..